Kawasaki Disease
📧 Sign up to get email alerts when something new happens for Kawasaki Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: Efficacy of Immunoglobulin Plus Prednisolone in Reducing Coronary Artery Lesion in Patients With Kawasaki Disease [Phase 3]
A Phase 3 trial evaluating whether adding immunoglobulin and prednisolone reduces coronary artery lesions in Kawasaki disease has completed.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Statins Study in Children of Acute Kawasaki Disease With Coronary Artery Abnormalities
This clinical trial investigates the use of statins in children with acute Kawasaki disease who have coronary artery abnormalities; the stud…
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: Cardiovascular Status of Children 5 Years After Kawasaki Disease
This completed trial update describes long-term cardiovascular outcomes in children five years after Kawasaki disease.
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Duke University-sponsored trial evaluating pharmacokinetics, pharmacodynamics, and safety of understudied drugs given to children as part of…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: MASKd: a Study on Kawasaki Disease (KD) Complicated by Macrophage Activation Syndrome (MAS)
A clinical trial named MASKd is studying Kawasaki disease complicated by macrophage activation syndrome and is currently not recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA CAR-NK Cell Injection for the Treatment of Refractory Pediatric Rheumatic Diseases [EARLY_Phase 1]
An early phase 1 exploratory trial is assessing the safety and potential efficacy of anti-CD19/BCMA CAR-NK cell injections for refractory pe…
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: Pilot Study of Atorvastatin and Anakinra in Children With Coronary Artery Abnormalities Secondary to Kawasaki Disease [EARLY_Phase 1]
This early-phase pilot trial evaluated the safety and feasibility of combining atorvastatin and anakinra in children with coronary artery ab…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Clinical Study on an Artificial Intelligence-Assisted Chest Radiograph Model Based on Big Data and Deep Learning for Early Detection of Kawasaki Disease
A planned clinical study employing an AI-assisted chest radiograph model using big data and deep learning to enable early detection of Kawas…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Doxycycline Treatment to Prevent Progressive Coronary Artery Dilation in Children With Kawasaki Disease [Phase 2]
Phase 2 clinical trial evaluating doxycycline to prevent progressive coronary artery dilation in children with Kawasaki disease; the study i…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Kawasaki MATCH Trial [NA]
The Kawasaki MATCH trial sponsored by the University of California, San Diego is currently recruiting for Kawasaki Disease.
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: European and North Indian Cohort of KaWasaki dIsease
This Clinical Trial Update reports ongoing recruitment for a Kawasaki disease study in European and North Indian cohorts sponsored by Meyer …
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Model-informed Dose Optimization for Rivaroxaban in Children With Giant Coronary Artery Aneurysm After Kawasaki Disease [Phase 4]
Phase 4 clinical trial assessing model-informed dose optimization of rivaroxaban in children with Kawasaki Disease who develop giant coronar…
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: Cardiovascular Risk in Children With Chronic Conditions Study
Clinical trial update indicates the Cardiovascular Risk in Children With Chronic Conditions Study, sponsored by Semmelweis University, is cu…
-
CLINICAL_TRIALS trial_result · 2025-08-01Clinical Trial Update: Characterization of Multisystem Inflammatory Syndrome in Children (MIS-C) and Its Relationship to Kawasaki Disease
This completed clinical trial reports on the characterization of Multisystem Inflammatory Syndrome in Children (MIS-C) and explores its rela…
-
CLINICAL_TRIALS research · 2025-07-02Clinical Trial Update: Rivaroxaban for Children Aged Over 2 Years With Giant Coronary Artery Aneurysms After Kawasaki Disease [Phase 4]
Phase 4 clinical trial update studying rivaroxaban in children over 2 years with giant coronary artery aneurysms following Kawasaki disease.…
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: Pharmacometrics Analysis of Rivaroxaban in Chinese Children Aged Over 2 Years
A pharmacometrics analysis of rivaroxaban in Chinese children over 2 years old is being conducted, with Kawasaki disease and coronary artery…
-
EMA approval · 2025-05-28EMA Authorised: Privigen (human normal immunoglobulin (IVIg)) — CSL Behring GmbH
Privigen (human normal immunoglobulin IVIg) has been authorised by the EMA for multiple indications. The listed therapeutic areas include id…
-
EMA approval · 2025-05-16EMA Authorised: Deqsiga (human normal immunoglobulin) — Takeda Manufacturing Austria AG
EMA authorised Deqsiga, a human normal immunoglobulin product from Takeda Manufacturing Austria AG, for several immunologic and neuropathic …
-
CLINICAL_TRIALS research · 2025-01-15Clinical Trial Update: Genome Analysis of Human Endogenous Retroviruses (HERVs)(COVID19) [NA]
This study recruits to analyze human endogenous retroviruses (HERVs) in the context of COVID-19 and Kawasaki disease to explore potential li…
-
CLINICAL_TRIALS research · 2024-11-21Clinical Trial Update: Non Inferiority KawasakI Trial With Anakinra [Phase 4]
This document reports a Phase 4 non-inferiority trial evaluating anakinra for Kawasaki disease. The study status is NOT_YET_RECRUITING.
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Magnetic Resonance Myocardial Stress Perfusion in Pediatric Patients with Cardiovascular Disease
A clinical trial update describes ongoing pediatric research on magnetic resonance myocardial stress perfusion in children with cardiovascul…
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: The Value of Cardiovascular Imaging in Kawasaki Disease
A clinical trial investigating the value of cardiovascular imaging in Kawasaki disease is currently enrolling by invitation at West China Se…
-
CLINICAL_TRIALS trial_result · 2024-06-13Clinical Trial Update: Kawasaki Disease During the COVID-19 Epidemic
Clinical trial investigating Kawasaki Disease conducted during the COVID-19 epidemic has completed. Sponsor: IRCCS Burlo Garofolo.
-
CLINICAL_TRIALS trial_result · 2024-03-04Clinical Trial Update: Anakinra in Infants and Children With Coronary Artery Abnormalities in Acute Kawasaki Disease [Phase 1, Phase 2]
Clinical trial updates evaluating anakinra in infants and children with coronary artery abnormalities due to Kawasaki disease (Phase 1/Phase…
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: A Trial Comparing the Efficacy and Safety of Anakinra Versus Intravenous Immunoglobulin (IVIG) Retreatment, in Patients With Kawasaki Disease Who Failed to Respond to Initial Standard IVIG Treatment [Phase 3]
A Phase 3 trial comparing Anakinra to IVIG retreatment in Kawasaki disease patients who did not respond to initial IVIG therapy is currently…